4 unchanged sentences
Amended and Restated Bylaws
−Removed: Offer letter by and between Arcus Biosciences, Inc.
−Removed: and Robert C.
−Removed: Goeltz II dated June 30, 2020.
−Removed: Offer letter by and between Arcus Biosciences, Inc.
−Removed: and Jennifer Jarrett dated September 10, 2020.
−Removed: Fourth Amendment dated October 16, 2020 to the Lease agreement dated September 30, 2015 between Arcus Biosciences, Inc.
+Added: Amended and Restated Common Stock Purchase Agreement dated January 31, 2021 between Arcus Biosciences, Inc.
+Added: and Gilead Sciences, Inc.
+Added: February 2, 2021
+Added: Fifth Amendment Dated April 1, 2021 to the Lease agreement dated September 30, 2015 between Arcus Biosciences, Inc.
and Hayward Point Eden I Limited Partnership.
13 unchanged sentences
Filed herewith.
+Added: Certain information has been omitted because it is both not material and would be competitively sensitive if publicly disclosed.
This certification is deemed not filed for purposes of section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
ARCUS BIOSCIENCES, INC.
−Removed: November 5, 2020
/s/ Terry Rosen
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 5, 2020
/s/ Robert C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.